Reading Time: < 1 minute Addex Therapeutics, a clinical-stage biopharmaceutical company, has reported its Q1 2024…
Tag: biopharmaceutical company
23andMe to Announce Q4 and Full Year FY2024 Financial Performance
Reading Time: < 1 minute 23andMe Holding Co. (Nasdaq: ME) has announced that it will be…
MacroGenics Sets Date for First Quarter 2024 Financial Results Conference Call
Reading Time: < 1 minute MacroGenics, Inc. (Nasdaq: MGNX), a leading biopharmaceutical company specializing in antibody-based…